Abstract

BackgroundFor several decades now an antagonism between Trypanosoma cruzi infection and tumor development has been detected. The molecular basis of this phenomenon remained basically unknown until our proposal that T. cruzi Calreticulin (TcCRT), an endoplasmic reticulum-resident chaperone, translocated-externalized by the parasite, may mediate at least an important part of this effect. Thus, recombinant TcCRT (rTcCRT) has important in vivo antiangiogenic and antitumor activities. However, the relevant question whether the in vivo antitumor effect of T. cruzi infection is indeed mediated by the native chaperone (nTcCRT), remains open. Herein, by using specific modified anti-rTcCRT antibodies (Abs), we have neutralized the antitumor activity of T. cruzi infection and extracts thereof, thus identifying nTcCRT as a valid mediator of this effect.MethodsPolyclonal anti-rTcCRT F(ab’)2 Ab fragments were used to reverse the capacity of rTcCRT to inhibit EAhy926 endothelial cell (EC) proliferation, as detected by BrdU uptake. Using these F(ab’)2 fragments, we also challenged the capacity of nTcCRT, during T. cruzi infection, to inhibit the growth of an aggressive mammary adenocarcinoma cell line (TA3-MTXR) in mice. Moreover, we determined the capacity of anti-rTcCRT Abs to reverse the antitumor effect of an epimastigote extract (EE). Finally, the effects of these treatments on tumor histology were evaluated.ResultsThe rTcCRT capacity to inhibit ECs proliferation was reversed by anti-rTcCRT F(ab’)2 Ab fragments, thus defining them as valid probes to interfere in vivo with this important TcCRT function. Consequently, during infection, these Ab fragments also reversed the in vivo experimental mammary tumor growth. Moreover, anti-rTcCRT Abs also neutralized the antitumor effect of an EE, again identifying the chaperone protein as an important mediator of this anti mammary tumor effect. Finally, as determined by conventional histological parameters, in infected animals and in those treated with EE, less invasive tumors were observed while, as expected, treatment with F(ab’)2 Ab fragments increased malignancy.ConclusionWe have identified translocated/externalized nTcCRT as responsible for at least an important part of the anti mammary tumor effect of the chaperone observed during experimental infections with T. cruzi.Electronic supplementary materialThe online version of this article (doi:10.1186/s12885-016-2764-5) contains supplementary material, which is available to authorized users.

Highlights

  • For several decades an antagonism between Trypanosoma cruzi infection and tumor development has been detected

  • We have shown that recombinant T. cruzi Calreticulin (TcCRT) (rTcCRT) inhibits angiogenesis in three vertebrate species (Rattus rattus, Gallus gallus and Homo sapiens sapiens) [9, 15, 17], and that it interferes with morphogenesis, migration and proliferation of endothelial cells (ECs) [9]

  • Results rTcCRT and its N-domain interactions with ECs can be interfered with Abs or Fucoidan rTcCRT contact with ECs is a prerequisite for the inhibition of cell proliferation and migration, two crucial events in angiogenesis [9]

Read more

Summary

Introduction

For several decades an antagonism between Trypanosoma cruzi infection and tumor development has been detected. We identify a protein from the Trypanosoma cruzi (the protozoan agent of Chagas disease) endoplasmic reticulum (ER), as responsible for, at least an important part of the antitumor effect of this infection. About 80 years ago, Roskin, Ekzempliarskaia and Klyuyeva, researchers from the former Soviet Union, postulated an experimental anticancer toxic activity derived from this infection When they inoculated T. cruzi extracts, directly in a peritumoral area, in different tumors, both in experimental animals and in humans, similar results to those obtained with the infection were generated. The parasite capacity to infect preferentially tumor cells, as compared to normal host cells, was described (reviewed in [2]) In general, these data suggest an antagonism between T. cruzi infection and tumor growth [3], research progress in these areas was seriously hampered by the intense international political problems of those years (i.e. the Cold War) [4, 5]. Several publications on these issues have appeared during the last decade [3, 6,7,8], the molecular basis of this phenomenon has remained elusive

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call